Compare
ICU Medical Inc vs Teleflex Inc vs Insulet Corp vs Globus Medical Inc
| Latest fiscal year | ICU Medical Inc ICUI | Teleflex Inc TFX | Insulet Corp PODD | Globus Medical Inc GMED |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $2.23B | $1.99B | $2.71B | $2.94B |
| Revenue growth (YoY) | -6.3% | +17.2% | +30.7% | +16.7% |
| Gross margin | 36.8% | 56.2% | 71.6% | 67.4% (computed) |
| Operating margin | 1.9% | 5.9% | 17.5% | 16.3% |
| Net margin | 0.0% | -45.4% | 9.1% | 18.3% |
| Net income | $732.0K | -$905.64M | $247.10M | $537.87M |
| EPS (Diluted) | $0.03 | -$20.25 | $3.48 | $3.92 |
| Operating cash flow | $179.85M | $96.68M | $569.30M | $753.45M |
| Free cash flow | $91.80M | $1.45M | $377.70M | $588.77M |
| Cash & equivalents | n/a | $378.56M | n/a | $526.16M |
| Total assets | $4.05B | $6.95B | $3.19B | $5.30B |
| Total liabilities | n/a | $3.82B | $1.68B | $729.51M |
| Shareholders' equity | $2.12B | $3.12B | $1.52B | $4.57B |
| Return on year-end equity | 0.0% | -29.0% | 16.3% | 11.8% |
| Shares outstanding | 24.69M | n/a | 70.39M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | ICU Medical Inc | Teleflex Inc | Insulet Corp | Globus Medical Inc |
|---|---|---|---|---|
| Latest | $2.23B Ended 2025-12-31 | $1.99B Ended 2025-12-31 | $2.71B Ended 2025-12-31 | $2.94B Ended 2025-12-31 |
| 1 year earlier | $2.38B Ended 2024-12-31 | $1.70B Ended 2024-12-31 | $2.07B Ended 2024-12-31 | $2.52B Ended 2024-12-31 |
| 2 years earlier | $2.26B Ended 2023-12-31 | $1.71B Ended 2023-12-31 | $1.70B Ended 2023-12-31 | $1.57B Ended 2023-12-31 |
| 3 years earlier | $2.28B Ended 2022-12-31 | $2.79B Ended 2022-12-31 | $1.31B Ended 2022-12-31 | $1.02B Ended 2022-12-31 |
| 4 years earlier | $1.32B Ended 2021-12-31 | $2.81B Ended 2021-12-31 | $1.10B Ended 2021-12-31 | $958.10M Ended 2021-12-31 |